Nuvation Bio, Inc. (NUVB)
4.59
+0.02
(+0.44%)
USD |
NYSE |
Mar 06, 16:00
4.45
-0.14
(-3.05%)
Pre-Market: 20:00
Nuvation Bio Shareholders Equity (Quarterly) : 305.72M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Corcept Therapeutics, Inc. | 647.80M |
| Aldeyra Therapeutics, Inc. | 44.25M |
| Indivior Pharmaceuticals, Inc. | -98.00M |
| Terns Pharmaceuticals, Inc. | 284.07M |
| Biohaven Ltd. | 52.07M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 594.82M |
| Total Liabilities (Quarterly) | 289.11M |
| Debt to Equity Ratio | 0.6959 |
| Current Ratio | 6.950 |
| Net Debt Paydown Yield | -1.31% |